Former CFO of GSK joins Revolymer board
Former GlaxoSmithKline CFO Julian Heslop joins Revolymer following admission to AIM
AS A CONSEQUENCE of its admission to the AIM Market, UK polymer company Revolymer has appointed Julian Heslop to its board as a non-executive director.
Heslop served as CFO of GlaxoSmithKline between April 2005 and March 2011. He was also Chairman of ViiV Healthcare until March 2011.
He served as senior vice president, operations controller of GSK between January 2001 and March 2005 and as financial controller of Glaxo Wellcome from April 1998 to December 2000.
Previously, Heslop had senior finance roles at Grand Metropolitan and Imperial Brewing and Leisure.
He is a fellow of the ICAEW.
Revolymer placed shares onto the exchange to raise £25m from institutional investors, and its market cap at the time of its listing will be approxiamtely £53m. The proceeds will be used to expand its distribution of its confectionary gum products in the US and Europe, fund regulatory documentation around the nicotine gum industry, and develop new products.
Its share price is 103.5p in this morning’s trading.
For more company and market information visit the Share Price Centre